2',5'-oligoadenylate phosphodiesterase
CA 2498771 A1 · Owner: Ozeki, Yohei · Inventors: Hara, Ayako; Ozeki, Yohei; Kubota, Kazuishi
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
It is intended to provide a novel polypeptide having a 2~,5~-oligoadenylate phosphodiesterase activity; an antibody against this polypeptide; a polynucleotide encoding the polypeptide; a recombinant plasmid DNA having this polynucleotide inserted thereinto; host cells transformed by this recombinant plasmid DNA; a method of screening a 2~,5~-oligoadenylate phosphodiesterase activity inhibitor; a method of screening a 2~,5~-oligoadenylate phosphodiesterase expression controller/inhibitor; etc. The above-described polypeptide, polynucleotide, host cells and so on are useful as means of searching for remedies for viral infection tumor, etc.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed September 11, 2003. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended September 11, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by September 11, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.